摘要
帕金森病是一种常见的精神退行性疾病的延伸,伴随着特征性运动症状。非机动功能障碍与治疗相关并发症时常发生,却经常被漏诊,没有接受治疗。Levodoba诱发性运动障碍和冲动控制障碍被认为共享病理生理学过程且可能与谷氨酸能神经传递的改变有关。抗谷氨酸干扰而因此值得思考:一些证据已经证明了他们的有利影响。犬尿酸途径提供了拮抗犬尿酸的内源性谷氨酸受体,这可能会成为一个未来药物发展的有希望的候选来评估帕金森病运动性症状以及治疗相关并发症。
关键词: 帕金森病,犬尿酸途径,精神退行性疾病,NMDA 受体,谷氨酸,Levodopa诱发性运动障碍,兴奋性毒性。
Current Medicinal Chemistry
Title:Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System
Volume: 23 Issue: 9
Author(s): Zsófia Majláth, József Toldi, Ferenc Fülöp, László Vécsei
Affiliation:
关键词: 帕金森病,犬尿酸途径,精神退行性疾病,NMDA 受体,谷氨酸,Levodopa诱发性运动障碍,兴奋性毒性。
摘要: Parkinson’s disease is a common progressive neurodegenerative disorder presenting with characteristic motor symptoms. Non-motor dysfunctions and therapyrelated complications frequently develop, but are often underdiagnosed and undertreated. Levodopa- induced dyskinesia and impulse control disorders are suggested to share pathophysiological processes and m a y be related to alterations of the glutamatergic neurotransmission. Anti- glutamatergic interventions are therefore worth considering: several lines of evidence already indicate their beneficial effect. The kynurenine pathway offers the endogenous glutamate receptor antagonist kynurenic acid, which may act as a promising candidate for future drug development with the aim of assessment of the motor symptoms and therapy-related complications of Parkinson’s disease.
Export Options
About this article
Cite this article as:
Zsófia Majláth, József Toldi, Ferenc Fülöp, László Vécsei , Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System, Current Medicinal Chemistry 2016; 23 (9) . https://dx.doi.org/10.2174/0929867323666160212121915
DOI https://dx.doi.org/10.2174/0929867323666160212121915 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
Current Medicinal Chemistry Pharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults
Current Psychiatry Reviews Nitric Oxide and Dietary Factors: Part IV Traditional Japanese Food (Soy Products, Fish and Tea)
Vascular Disease Prevention (Discontinued) Therapeutic Strategies in Parkinsons Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Patents on Epilepsy Genetics
Recent Patents on DNA & Gene Sequences Cannabinoids: Between Neuroprotection and Neurotoxicity
Current Drug Targets - CNS & Neurological Disorders Risk Factors and Metabolism of Different Brain Regions by Positron Emission Tomography in Parkinson Disease with Disabling Dyskinesia
Current Neurovascular Research Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Omega-3 Fatty Acids: Role in the Prevention and Treatment of Psychiatric Disorders
Current Psychiatry Reviews Minocycline Inhibits mTOR Signaling Activation and Alleviates Behavioral Deficits in the Wistar Rats with Acute Ischemia stroke
CNS & Neurological Disorders - Drug Targets Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Current Neuropharmacology Thioridazine: The Good and the Bad
Recent Patents on Anti-Infective Drug Discovery Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders
Current Drug Therapy Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia
CNS & Neurological Disorders - Drug Targets Changing Faces of Transcriptional Regulation Reflected by Zic3
Current Genomics Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Current Neuropharmacology Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment
CNS & Neurological Disorders - Drug Targets [General Articles] Cannabinoids: Mechanisms and Therapeutic Applications in the CNS
Current Medicinal Chemistry Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Recent Advances in Progressive Supranuclear Palsy: A Review
Current Alzheimer Research